Fluzone®

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
21	ミトコンドリア病	1

21. ミトコンドリア病

臨床試験数 : 39 / 薬物数 : 42 - (DrugBank : 32) / 標的遺伝子数 : 47 - 標的パスウェイ数 : 67

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01831934 (ClinicalTrials.gov)	September 2010	19/3/2013	Responses to Influenza Vaccine in Patients With Mitochondrial Disorders (MELAS)	Metabolic and Immune Responses to TIV in Patients With Mitochondrial Disease	MELAS Syndrome	Biological: Fluzone®	Stanford University	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Completed	13 Years	65 Years	All	22	Phase 4	United States

First Previous1Next Last